Disorders of mitochondrial fatty acyl‐CoA β‐oxidation
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
In recent years tremendous progress has been made with respect to the enzymology of the mitochondrial fatty acid β‐oxidation machinery and defects therein. Firstly, a number of new mitochondrial β‐oxidation enzymes have been identified, including very‐long‐chain acyl‐CoA dehydrogenase (VLCAD) and mitochondrial trifunctional protein (MTP). Secondly, the introduction of tandem MS for the analysis of plasma acylcarnitines has greatly facilitated the identification of patients with a defect in fatty acid oxidation (FAO). These two developments explain why the number of defined FAO disorders has increased dramatically, making FAO disorders the most rapidly growing group of inborn errors of metabolism. In this review we describe the current state of knowledge of the enzymes involved in the mitochondrial oxidation of straight‐chain, branched‐chain and (poly)unsaturated fatty acyl‐CoAs as well as disorders of fatty acid oxidation. The laboratory diagnosis of these disorders is described, with particular emphasis on the methods used to identify the underlying enzyme defect and the molecular mutations. In addition, a simple flowchart is presented as a guide to the identification of mitochondrial FAO‐disorders. Finally, treatment strategies are discussed briefly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients afflicted with these disorders present with nonketotic hypoglycemia, muscle weakness, pronounced elevations in long chain acylcarnitines and systemic carnitine depletion [91].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [91]
Citations
Cites
Ciabarra, A., Sullivan, J., Gahn, L., Pecht, G., Heinemann, S., & Sevarino, K. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06498.1995 · Cited by 1,233
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_6838 · Cited by 648
Millington, D. S., Kodo, N., Norwood, D. L., & Roe, C. R. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799385 · Cited by 571 · cited 1×
“…clear, however, that tandem mass spectrometry is the method of choice for the analysis of acylcarnitines, especially since acylcarnitine proÐles can readily be determined not only in plasma or serum samples but also in blood spots (Millington et al 1990 ; Rashed et al 1995a,b ; Vreken et al 1999).”
Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria
DiMauro, S., & DiMauro, P. M. M. (1973) · Science · doi:10.1126/science.182.4115.929 · Cited by 477 · cited 2×
“Schaefer and coworkers (1996) described three adult patients from the same family with symptoms of recurrent exercise-induced rhabdomyolysis mimicking adult-type CPT2 deÐciency (DiMauro and DiMauro 1973) except that these patients had an associated peripheral neuropathy.”
BackgroundRashed, M. S., Ozand, P. T., Bucknall, M. P., & Little, D. (1995) · Pediatric Research · doi:10.1203/00006450-199509000-00009 · Cited by 342 · cited 2×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundUchida, Y., Izai, K., Orii, T., & Hashimoto, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48391-3 · Cited by 339 · cited 9×
“It is now clear that the long-chain enzyme identiÐed by Schulz (1974) is in fact a constituent of the mitochondrial trifunctional protein (MTP) identiÐed by Hashimoto and coworkers (Uchida et al 1992).”
BackgroundInfluentialAndresen, B. S., Olpin, S., Poorthuis, B. J. H. M., Scholte, H. R., Vianey-Saban, C., Wanders, R., Ijlst, L., Morris, A., Pourfarzam, M., Bartlett, K., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302261 · Cited by 305 · cited 2×
“Since these reports in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of…”
BackgroundSelf-citationChace, D. H., Hillman, S. L., Van Hove, J. L. K., & Naylor, E. W. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2106 · Cited by 280 · cited 1×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundRashed, M. S., Bucknall, M. P., Little, D., Awad, A., Jacob, M., Alamoudi, M., Alwattar, M., & Ozand, P. T. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1129 · Cited by 275
Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
Iafolla, A. K., Thompson, R. J., & Roe, C. R. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70363-9 · Cited by 274
Izai, K., Uchida, Y., Orii, T., Yamamoto, S., & Hashimoto, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48390-1 · Cited by 245 · cited 3×
“This apparent discrepancy was resolved when Hashimoto and coworkers (Izai et al 1992) identiÐed a fourth acylCoA dehydrogenase with preference for long-chain and very-long-chain acyl-CoAs and therefore called VLCAD.”
BackgroundSims, H. F., Brackett, J. C., Powell, C. K., Treem, W. R., Hale, D. E., Bennett, M. J., Gibson, B., Shapiro, S., & Strauss, A. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.841 · Cited by 222 · cited 1×
“Molecular basis of L CHAD and MT P deÐciency : In LCHAD-deÐcient patients a common mutation has been identiÐed (1528G [ C) that changes a glutamate residue into glutamine at position 510 of the a-subunit (IJlst et al 1994, 1996 ; Sims et al 1995).”
BackgroundIkeda, Y., Okamura-Ikeda, K., & Tanaka, K. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71245-7 · Cited by 219
An acyl-coenzyme a dehydrogenase assay utilizing the ferricenium ion
Lehman, T. C., Hale, D. E., Bhala, A., & Thorpe, C. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90080-s · Cited by 214
Ruzicka, F. J., & Beinert, H. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75238-7 · Cited by 210 · cited 1×
“ETF is a dimer of two nonidentical subunits, a and b, and contains one FAD molecule per dimer (Furuta et al 1981), whereas ETF:ubiquinone oxidoreductase is a 68 kDa Ñavoprotein (Beckmann and Frerman 1985 ; Ruzicka and Beinert 1977) (Figure 2).”
BackgroundMedium-Chain Acyl-CoA Dehydrogenase Deficiency
Rinaldo, P., O'Shea, J. J., Coates, P. M., Hale, D. E., Stanley, C. A., & Tanaka, K. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192003 · Cited by 209
Long-Chain Acyl Coenzyme A Dehydrogenase Deficiency: An Inherited Cause of Nonketotic Hypoglycemia
Hale, D. E., Batshaw, M. L., Coates, P. M., Frerman, F. E., Goodman, S. I., Singh, I., & Stanley, C. A. (1985) · Pediatric Research · doi:10.1203/00006450-198507000-00006 · Cited by 202 · cited 2×
“This method developed by Frerman and Goodman (1985) has been applied to the diagnosis of SCAD, MCAD and (V)LCAD deÐency in Ðbroblasts, tissue samples (e.g. liver) and mononuclear cells, notably by Hale and coworkers (Coates et al 1985, 1988 ; Hale et al 1985).”
BackgroundMethodDemaugre, F., Bonnefont, J. P., Colonna, M., Cepanec, C., Leroux, J. P., & Saudubray, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115090 · Cited by 198 · cited 1×
“Carnitine palmitoyltransferases 1 and 2: Both transferases are expressed in lymphocytes and can readily be measured in lymphocytes using established techniques (Demaugre et al 1988, 1991).”
MethodThe Presence of a New 3‐Oxoacyl‐CoA Thiolase in Rat Liver Peroxisomes
MIYAZAWA, S., OSUMI, T., & HASHIMOTO, T. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb05984.x · Cited by 197
Stanley, C. A., Hale, D. E., Coates, P. M., Hall, C. L., Corkey, B. E., Yang, W., Kelley, R. I., Gonzales, E. L., Williamson, J. R., & Baker, L. (1983) · Pediatric Research · doi:10.1203/00006450-198311000-00008 · Cited by 192 · cited 1×
“A major breakthrough was the discovery of medium-chain acyl-CoA dehydrogenase deÐciency in the early 1980s (Kolvra a et al 1982 ; Rhead et al 1983 ; Stanley et al 1983).”
BackgroundON THE MECHANISM OF DEHYDROGENATION OF FATTY ACYL DERIVATIVES OF COENZYME A
Crane, F. L., & Beinert, H. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65837-5 · Cited by 190
Ikeda, Y., Dabrowski, C., & Tanaka, K. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33160-0 · Cited by 172 · cited 1×
“The three enzymes have been puriÐed to apparent homogeneity from several sources including rat liver (Furuta et al 1981 ; Ikeda et al. 1983, 1985) and all turned out to be soluble, mitochondrial matrix enzymes composed of four identical subunits with a native molecular mass of 160È180 kDa.”
BackgroundAmendt, B. A., Greene, C., Sweetman, L., Cloherty, J., Shih, V, Moon, A., Teel, L., & Rhead, W. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112953 · Cited by 170 · cited 3×
“Later studies revealed normal SCAD activity in Ðbroblasts (Amendt et al 1987 ; Coates et al 1988), which excludes generalized SCAD deÐciency.”
BackgroundMethodStrauss, A. W., Powell, C. K., Hale, D. E., Anderson, M. M., Ahuja, A., Brackett, J. C., & Sims, H. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10496 · Cited by 169 · cited 1×
“Subsequent studies have shown that, in contrast to MCAD deÐciency, the molecular basis of VLCAD deÐciency is very diverse with numerous mutations (Andresen et al 1999 ; Aoyama et al 1995a ; Souri et al 1996 ; Strauss et al 1995).”
BackgroundBonnefont, J. P., Specola, N. B., Vassault, A., Lombes, A., Ogier, H., de Klerk, J. B. C., Munnich, A., Coude, M., Paturneau-Jouas, M., & Saudubray, J. M. (1990) · European Journal of Pediatrics · doi:10.1007/bf02072043 · Cited by 168
Kølvraa, S., Gregersen, N., Christensen, E., & Hobolth, N. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90361-8 · Cited by 166
Aoyama, T., Souri, M., Ushikubo, S., Kamijo, T., Yamaguchi, S., Kelley, R. I., Rhead, W. J., Uetake, K., Tanaka, K., & Hashimoto, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117947 · Cited by 164 · cited 2×
“Since these reports in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of…”
BackgroundIJlst, L., Ruiter, J. P., Hoovers, J. M., Jakobs, M. E., & Wanders, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118863 · Cited by 163 · cited 2×
“Molecular basis of L CHAD and MT P deÐciency : In LCHAD-deÐcient patients a common mutation has been identiÐed (1528G [ C) that changes a glutamate residue into glutamine at position 510 of the a-subunit (IJlst et al 1994, 1996 ; Sims et al 1995).”
BackgroundSelf-citationMatsubara, Y., Indo, Y., Naito, E., Ozasa, H., Glassberg, R., Vockley, J., Ikeda, Y., Kraus, J., & Tanaka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71624-4 · Cited by 160 · cited 1×
“The cDNA sequences of the three rat (SCAD, Matsubara et al 1989 ; MCAD, Matsubara et al 1986 ; LCAD, Matsubara et al 1989) and human (SCAD, Naito et al 1989 ; MCAD, Matsubara et al 1986 ; Kelly et al 1987 ; LCAD, Indo et al 1991b) acyl-CoA dehdyrogenases have all been determined, which allowed…”
BackgroundIJlst, L., Wanders, R. J. A., Ushikubo, S., Kamijo, T., & Hashimoto, T. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90064-7 · Cited by 158 · cited 1×
“Molecular basis of L CHAD and MT P deÐciency : In LCHAD-deÐcient patients a common mutation has been identiÐed (1528G [ C) that changes a glutamate residue into glutamine at position 510 of the a-subunit (IJlst et al 1994, 1996 ; Sims et al 1995).”
BackgroundSelf-citationVianey‐Saban, C., Divry, P., Brivet, M., Nada, M. A. R., Zabot, M. T., Mathieu, M., & Roe, C. R. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00185-x · Cited by 156 · cited 3×
“Onkenhout and colleagues (1995) have advocated the use of total fatty acids analysis of serum by GC-MS, which also shows profound abnormalities in cases of VLCAD deÐciency (Smelt et al 1998 ; Vianey-Saban et al 1998).”
BackgroundMethodManning, N. J., Olpin, S. E., Pollitt, R. J., & Webley, J. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799333 · Cited by 152 · cited 2×
“Incubation of(C14>0) intact Ðbroblasts with these fatty acids usually gives deÐcient rates of [3H]H2O production with most enzyme deÐciencies (Manning et al 1990 ; Olpin et al 1992 ; Ventura et al 1998).”
BackgroundMethodHuman trifunctional protein deficiency: A new disorder of mitochondrial fatty acid β-oridation
Wanders, R. J. A., IJlst, L., Poggi, F., Bonnefont, J., Münnich, A., Brivet, M., Rabier, D., & Saudubray, J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91350-y · Cited by 152 · cited 6×
“MT P-deÐciency : After its Ðrst description in 1992 by two di†erent groups (Jackson et al 1992 ; Wanders et al 1992), very few additional patients have been described (Brackett et al 1995 ; Dionisi-Vici et al 1996 ; Ibdah et al 1998 ; Ushikubo et al 1996).”
BackgroundMethodInfluentialSelf-citationA Novel Disease with Deficiency of Mitochondrial Very-Long-Chain Acyl-CoA Dehydrogenase
Aoyama, T., Uchida, Y., Kelley, R. I., Marble, M., Hofman, K., Tonsgard, J. H., Rhead, W. J., & Hashimoto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1368 · Cited by 150 · cited 1×
“Independent studies by two other groups (Aoyama et al 1993 ; Bertrand et al 1993) led to the same conclusion.”
ResultProperties of Mitochondrial and Peroxisomal Enoyl-CoA Hydratases from Rat Liver1
FURUTA, S., MIYAZAWA, S., OSUMI, T., HASHIMOTO, T., & UI, N. (1980) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133057 · Cited by 150 · cited 1×
“The enzyme has subsequently been puriÐed from several sources including pig heart (Fong and Schulz 1977) and rat liver (Furuta et al 1980) and is composed of six identical subunits.”
BackgroundCARPENTER, K., Pollitt, R. J., & Middleton, B. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90501-b · Cited by 144
Vreken, P., van Lint, A. E. M., Bootsma, A. H., Overmars, H., Wanders, R. J. A., & Gennip, A. H. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005587617745 · Cited by 141
Self-citationKunau, W., & DOMMES, P. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12707.x · Cited by 138 · cited 1×
“an odd-numbered position require *3,*2-enoyl-CoA isomerase as auxiliary enzyme, whereas another auxiliary enzyme, called 2,4-dienoyl-CoA reductase, participates in the b-oxidation of fatty acids with a double bond at an even-numbered position (Kunau and Dommes 1978).”
BackgroundTyni, T., Palotie, A., Viinikka, L., Valanne, L., Salo, M. K., von Döbeln, U., Jackson, S., Wanders, R., Venizelos, N., & Pihko, H. (1997) · Jornal de Pediatria · doi:10.1016/s0022-3476(97)70312-3 · Cited by 138 · cited 1×
“22 (1999) The phenotypic heterogeneity of LCHAD deÐciency is enormous, with some patients presenting immediately after birth with rapidly fatal cardiomyopathy (Rocchiccioli et al 1990 ; Tyni et al 1997).”
BackgroundSelf-citationTurnbull, D. M., Bartlett, K., Stevens, D. L., Alberti, K. G. M. M., Gibson, G. J., Johnson, M. A., McCulloch, A. J., & Sherratt, H. S. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411083111906 · Cited by 132 · cited 1×
“Clinical presentation : Seemingly the Ðrst case of SCAD deÐciency was reported in 1984 by Turnbull and coworkers (Turnbull et al 1984) in a middle-aged woman with progressive muscle weakness, lipid storage myopathy, muscle carnitine deÐciency plus combined ethylmalonicÈmethylsuccinic aciduria.”
BackgroundOsumi, T., & Hashimoto, T. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90189-7 · Cited by 132 · cited 1×
“The short-chain enzyme (SCHAD) was puriÐed in the early 1950s, and more recently by Noyes and Bradshaw (1973) and Osumi and Hashimoto (1980) from pig heart and rat liver, respectively, and is a dimer of two identical subunits of 33 kDa each.”
BackgroundDemaugre, F., Bonnefont, J., Mitchell, G. A., Nguyen-Hoang, N., Pelet, A., Rimoldi, M., Donato, S. D., & Saudubray, J. (1988) · Pediatric Research · doi:10.1203/00006450-198809000-00006 · Cited by 131
Verhoeven, N. M., Roe, D. S., Kok, R. M., Wanders, R. J. A., Jakobs, C., & Roe, C. R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34204-8 · Cited by 131
Self-citationSUDDEN INFANT DEATH AND LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE
Wanders, R. J. A., Durán, M., IJlst, L., de Jager, J. P., Gennip, A. H., Jakobs, C., DORLAND, L., & van Sprang, F. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90300-0 · Cited by 130
Self-citationPurification and Properties of Rat Liver Acyl-CoA Dehydrogenases and Electron Transfer Flavoprotein1
FURUTA, S., MAYAZAWA, S., & HASHIMOTO, T. (1981) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133651 · Cited by 128 · cited 2×
“The three enzymes have been puriÐed to apparent homogeneity from several sources including rat liver (Furuta et al 1981 ; Ikeda et al. 1983, 1985) and all turned out to be soluble, mitochondrial matrix enzymes composed of four identical subunits with a native molecular mass of 160È180 kDa.”
BackgroundThe metabolism of phytanic acid and pristanic acid in man: A review
Verhoeven‐Duif, N. M., Wanders, R. J. A., Poll‐The, B. T., Saudubray, J., & Jakobs, C. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005476631419 · Cited by 128
Self-citationCombined enzyme defect of mitochondrial fatty acid oxidation.
Jackson, S., Kler, R. S., Bartlett, K., Briggs, H., Bindoff, L. A., Pourfarzam, M., Gardner-Medwin, D., & Turnbull, D. M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115983 · Cited by 127
Berge, R. K., Flatmark, T., & Osmundsen, H. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08239.x · Cited by 126
Purification and Characterization of an alpha-Methylacyl-CoA Racemase from Human Liver
Schmitz, W., Albers, C., Fingerhut, R., & Conzelmann, E. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20766.x · Cited by 124
Rocchicciolo, F., Wanders, R. J. A., Aubourg, P. R., Vianey‐Saban, C., Ijlst, L., Fabrè, M., Cartier, N., & Bougneres, P. F. (1990) · Pediatric Research · doi:10.1203/00006450-199012000-00023 · Cited by 123 · cited 1×
“22 (1999) The phenotypic heterogeneity of LCHAD deÐciency is enormous, with some patients presenting immediately after birth with rapidly fatal cardiomyopathy (Rocchiccioli et al 1990 ; Tyni et al 1997).”
BackgroundSelf-citationKelly, D. P., Kim, J. J., Billadello, J. J., Hainline, B. E., Chu, T. W., & Strauss, A. W. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4068 · Cited by 121
Bertrand, C., Largillière, C., Zabot, M. T., Mathieu, M., & Vianey‐Saban, C. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90058-9 · Cited by 121 · cited 1×
“Independent studies by two other groups (Aoyama et al 1993 ; Bertrand et al 1993) led to the same conclusion.”
ResultGregersen, N. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.4.619 · Cited by 121
Yamaguchi, S., Indo, Y., Coates, P. M., Hashimoto, T., & Tanaka, K. (1993) · Pediatric Research · doi:10.1203/00006450-199307000-00025 · Cited by 119 · cited 2×
“In cells from these patients, palmitate oxidation was strongly deÐcient, yet analysis of LCAD at the protein (immunoblotting) and cDNA level revealed no abnormalities (Yamaguchi et al 1993).”
BackgroundIkeda, Y., & Tanaka, K. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33161-2 · Cited by 117 · cited 2×
“Apart from SCAD, MCAD, LCAD, VLCAD and SBCAD, two additional acylCoA dehydrogenases have been identiÐed including isovaleryl-CoA dehydrogenase (IVD), Ðrst puriÐed and characterized by Ikeda and Tanaka (1983b) and glutarylCoA dehydrogenase (Goodman et al 1995).”
MethodPurification and properties of an α‐methylacyl‐CoA racemase from rat liver
SCHMITZ, W., FINGERHUT, R., & CONZELMANN, E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18870.x · Cited by 116 · cited 2×
“A Ðrst racemase was puriÐed from rat liver (Schmitz et al 1994).”
BackgroundMethodCoates, P. M., Hale, D. E., Stanley, C. A., Corkey, B. E., & Cortner, J. A. (1985) · Pediatric Research · doi:10.1203/00006450-198507000-00007 · Cited by 116 · cited 2×
“With octanoyl-CoA as substrate, residual activities are usually \10% (Coates et al 1985).”
MethodMolecular cloning and nucleotide sequence of the HU-1 gene of Escherichia coli
Kano, Y., Yoshino, S., Wada, M., Yokoyama, K., Nobuhara, M., & Imamoto, F. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00425687 · Cited by 116
Staack, H., Binstock, J. F., & Schulz, H. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62326-4 · Cited by 115 · cited 1×
“The enzyme has been puriÐed from several sources including pig liver (Staack et al 1978) and rat liver (Miyazawa et al 1980).”
BackgroundFluorometric assay of acyl-CoA dehydrogenases in normal and mutant human fibroblasts
Frerman, F. E., & Goodman, S. I. (1985) · Biochemical Medicine · doi:10.1016/0006-2944(85)90124-3 · Cited by 115 · cited 2×
“Table 1 lists the residual SCAD activities as measured in Ðbroblast homogenates from the 10 patients using the ETF-based assay developed by Frerman and Goodman (1985).”
MethodAndresen, B. S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.461 · Cited by 114 · cited 1×
“Since these reports in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of…”
BackgroundOgilvie, I. M., Pourfarzam, M., Jackson, S., Stockdale, C., Bartlett, K., & Turnbull, D. M. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.467 · Cited by 110 · cited 2×
“…a variety of dicarboxylic acids including adipic, suberic, sebacic and dodecanedioic acids, although several reports have documented mild (Hale et al 1985 ; Merinero et al 1996) to fully normal dicarboxylics both during and between attacks (Hale et al 1990 ; Ogilvie et al 1994 ; Smelt et al 1998).”
BackgroundIkeda, Y., & Tanaka, K. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44692-8 · Cited by 109 · cited 2×
“Apart from SCAD, MCAD, LCAD, VLCAD and SBCAD, two additional acylCoA dehydrogenases have been identiÐed including isovaleryl-CoA dehydrogenase (IVD), Ðrst puriÐed and characterized by Ikeda and Tanaka (1983b) and glutarylCoA dehydrogenase (Goodman et al 1995).”
MethodRhead, W. J., Amendt, B. A., Fritchman, K., & Felts, S. J. (1983) · Science · doi:10.1126/science.6857268 · Cited by 108 · cited 1×
“A major breakthrough was the discovery of medium-chain acyl-CoA dehydrogenase deÐciency in the early 1980s (Kolvra a et al 1982 ; Rhead et al 1983 ; Stanley et al 1983).”
BackgroundRashed, M. S., Ozand, P. T., Bennett, M. J., Barnard, J. J., Govindaraju, D. R., & Rinaldo, P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.8.1109 · Cited by 107 · cited 2×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundClinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency
Bhala, A., Willi, S. M., Rinaldo, P., Bennett, M. J., Schmidt‐Sommerfeld, E., & Hale, D. E. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70207-5 · Cited by 107 · cited 1×
“Patient 5, only brieÑy described (Bhala et al 1995), presented in the neonatal period and had delayed speech development and hyperactivity at 2 years of age.”
BackgroundUshikubo, S., Aoyama, T., Kamijo, T., Wanders, R. J. A., Rinaldo, P., Vockley, J. E., & Hashimoto, T. (1996) · PubMed Central · Cited by 104
Self-citationEvidence for Intermediate Channeling in Mitochondrial β -Oxidation
Nada, M. A., Rhead, W. J., Sprecher, H., Schulz, H., & Roe, C. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.530 · Cited by 103
Yokota, I., Indo, Y., Coates, P. M., & Tanaka, K. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114761 · Cited by 102 · cited 1×
“Molecular basis of MCAD deÐciency : Studies in the early 1990s revealed the existence of a single, highly prevalent mutation among MCAD-deÐcient patients (Gregersen et al 1991 ; Kelly et al 1990 ; Yokota et al 1990).”
BackgroundCoates, P. M., Hale, D. E., Finocchiaro, G., Tanaka, K., & Winter, S. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113290 · Cited by 102 · cited 2×
“Later studies revealed normal SCAD activity in Ðbroblasts (Amendt et al 1987 ; Coates et al 1988), which excludes generalized SCAD deÐciency.”
BackgroundMethodl-3-Hydroxyacyl Coenyzme A Dehydrogenase from Pig Heart Muscle
Noyes, B. E., & Bradshaw, R. A. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44008-8 · Cited by 101
Corydon, M. J., Gregersen, N. V., Lehnert, W., Ribes, A., Rinaldo, P., Kmoch, S., Christensen, E., Kristensen, T. J., Andresen, B. S., Bross, P., et al. (1996) · Pediatric Research · doi:10.1203/00006450-199606000-00021 · Cited by 99
Kamijo, T., Aoyama, T., Komiyama, A., & Hashimoto, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1302 · Cited by 98 · cited 1×
“The cDNA structures for both subunits have been determined both for rat (Kamijo et al 1993) and man (Kamijo et al 1994), and the structure of the human genes coding for the a- and b- subunits has been resolved (Yang et al 1996).”
BackgroundTwo alpha subunit donor splice site mutations cause human trifunctional protein deficiency.
Brackett, J. C., Sims, H. F., Rinaldo, P., Shapiro, S., Powell, C. K., Bennett, M. J., & Strauss, A. W. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117894 · Cited by 95 · cited 2×
“MT P-deÐciency : After its Ðrst description in 1992 by two di†erent groups (Jackson et al 1992 ; Wanders et al 1992), very few additional patients have been described (Brackett et al 1995 ; Dionisi-Vici et al 1996 ; Ibdah et al 1998 ; Ushikubo et al 1996).”
BackgroundBeckmann, J. D., & Frerman, F. E. (1985) · Biochemistry · doi:10.1021/bi00336a016 · Cited by 94 · cited 4×
“22 (1999) chondrial matrix, has FAD as prosthetic group, and in turn passes reducing equivalents to another Ñavoprotein called ETF:ubiquinone oxidoreductase.”
BackgroundInfluentialFong, J. C., & Schulz, H. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32751-5 · Cited by 93 · cited 1×
“The enzyme has subsequently been puriÐed from several sources including pig heart (Fong and Schulz 1977) and rat liver (Furuta et al 1980) and is composed of six identical subunits.”
BackgroundKler, R. S., Jackson, S., Bartlett, K., Bindoff, L. A., Eaton, S. D., Pourfarzam, M., Frerman, F. E., Goodman, S. I., Watmough, N. J., & Turnbull, D. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54444-6 · Cited by 92
Smeland, T. E., Nada, M., Cuebas, D., & Schulz, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6673 · Cited by 92
Bross, P., Jespersen, C., Jensen, T. G., Andresen, B. S., Kristensen, M. J., Winter, V., Nandy, A., Kräutle, F.-G., Ghisla, S., Bolund, L., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10284 · Cited by 91 · cited 1×
“Studies by Gregersen and coworkers (Bross et al 1995) have shown that the K304E mutation a†ects polypeptide folding rather than the stability of the assembled enzyme.”
BackgroundMolecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency.
Kelly, D. P., Whelan, A. J., Ogden, M. L., Alpers, R., Zhang, Z. F., Bellus, G., Gregersen, N., Dorland, L., & Strauss, A. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9236 · Cited by 89 · cited 1×
“Molecular basis of MCAD deÐciency : Studies in the early 1990s revealed the existence of a single, highly prevalent mutation among MCAD-deÐcient patients (Gregersen et al 1991 ; Kelly et al 1990 ; Yokota et al 1990).”
BackgroundKamijo, T., Aoyama, T., Miyazaki, J., & Hashimoto, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74336-1 · Cited by 88
Very Long Chain Acyl-CoA Dehydrogenase Deficiency: Successful Treatment of Acute Cardiomyopathy
Brown‐Harrison, M., Nada, M. A. R., Sprecher, H. W., Vianey‐Saban, C., John Farquhar, Jr., Gilladoga, A. C., & Roe, C. R. (1996) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1996.0033 · Cited by 86 · cited 1×
“Since these reports in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of…”
BackgroundVentura, F. V., Costa, C. G., Struys, E. A., Ruiter, J. P. N., Allers, P., IJlst, L., de Almeida, I. T., Durán, M., Jakobs, C., & Wanders, R. J. A. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00188-0 · Cited by 86 · cited 6×
“In the original work, GC-MS was used for acylcarnitine analysis (Ventura et al 1999).”
BackgroundMethodInfluentialSelf-citationTein, I., Vivo, D. C. D., Hale, D. E., Clarke, J. T. R., Zinman, H. M., Laxer, R. M., Shore, A., & DiMauro, S. (1991) · Annals of Neurology · doi:10.1002/ana.410300315 · Cited by 84
Ackman, R. G., & Hansen, R. P. (1967) · Lipids · doi:10.1007/bf02531848 · Cited by 82 · cited 1×
“Naturally occuring phytanic acid is a mixture of two di†erent diastereomers, (3S, 7R,11R)- and (3R,7R,11R)-phytanic acid (Ackman and Hansen 1967).”
BackgroundGlasgow, A. M., Engel, A. G., Bier, D. M., Perry, L. W., Dickie, M. W., Todaro, J., Brown, B. I., & Utter, M. F. (1983) · Pediatric Research · doi:10.1203/00006450-198305000-00003 · Cited by 82 · cited 1×
“…deÐciency : The Ðrst case of biochemically proven LCHAD deÐciency was published in 1989 (Wanders et al 1989), although subsequent retrospective studies revealed that some patients described earlier with an unidentiÐed defect in boxidation did in fact su†er from LCHAD deÐciency (Glasgow et al 1983).”
Short-chain acyl–CoA dehydrogenase deficiency: A cause of ophthalmoplegia and multicore myopathy
Tein, I., Haslam, R. H. A., Rhead, W. J., Bennett, M. J., Becker, L. E., & Vockley, J. (1999) · Neurology · doi:10.1212/wnl.52.2.366 · Cited by 82
Naito, E., Indo, Y., & Tanaka, K. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114607 · Cited by 82 · cited 1×
“Molecular basis of SCAD deÐciency : The identiÐcation of the human SCAD cDNA (Naito et al 1989) allowed resolution of the molecular basis of SCAD deÐciency as Ðrst described by (Naito et al 1990).”
MethodNaito, E., Ozasa, H., Ikeda, Y., & Tanaka, K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114058 · Cited by 81 · cited 3×
“The cDNA sequences of the three rat (SCAD, Matsubara et al 1989 ; MCAD, Matsubara et al 1986 ; LCAD, Matsubara et al 1989) and human (SCAD, Naito et al 1989 ; MCAD, Matsubara et al 1986 ; Kelly et al 1987 ; LCAD, Indo et al 1991b) acyl-CoA dehdyrogenases have all been determined, which allowed…”
BackgroundMethodAoyama, T., Ueno, I., Kamijo, T., & Hashimoto, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32278-0 · Cited by 79
Two Mitochondrial 3-Hydroxyacyl-CoA Dehydrogenases in Bovine Liver
Kobayashi, A., Jiang, L. L., & Hashimoto, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021307 · Cited by 79
Bennett, M. J., Weinberger, M. J., Kobori, J. A., Rinaldo, P., & Burlina, A. (1996) · Pediatric Research · doi:10.1203/00006450-199601000-00031 · Cited by 78 · cited 1×
“…acid as most prominent peak plus saturated and unsaturated 3- hydroxydicarboxylic aciduria of chain lengths with relatively largerC6ÈC14 amounts of the shorter chain length intermediates so that the proÐle is in fact a mirror-image of the pattern seen in LCHAD deÐciency (Bennett et al 1996).”
BackgroundIbdah, J. A., Tein, I., Dionisi-Vici, C., Bennett, M. J., IJlst, L., Gibson, B., Wanders, R. J., & Strauss, A. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2091 · Cited by 77 · cited 2×
“MT P-deÐciency : After its Ðrst description in 1992 by two di†erent groups (Jackson et al 1992 ; Wanders et al 1992), very few additional patients have been described (Brackett et al 1995 ; Dionisi-Vici et al 1996 ; Ibdah et al 1998 ; Ushikubo et al 1996).”
BackgroundSelf-citationArakawa, H., Takiguchi, M., Amaya, Y., Nagata, S., Hayashi, H., & Mori, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02376.x · Cited by 76 · cited 1×
“The cDNA sequences corresponding to the rat (Arakawa et al 1987 ; Miura et al 1986) and human (Abe et al 1993) mitochondrial “general Ï thiolase have been determined.”
MethodLong Chain Enoyl Coenzyme A Hydratase from Pig Heart
Schulz, H. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42686-0 · Cited by 76
Molecular cloning and sequence analysis of the cDNA for rat mitochondrial enoyl‐CoA hydratase
Ishii-Minami, N., Taketani, S., Osumi, T., & Hashimoto, T. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15083.x · Cited by 74 · cited 1×
“The cDNAs coding for rat liver (Minami-Ishii et al 1989) and human liver (Kanazawa et al 1993) crotonase have been cloned.”
BackgroundMatsubara, Y., Kraus, J. P., Yang-Feng, T. L., Francke, U., Rosenberg, L., & Tanaka, K. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6543 · Cited by 74
Fukao, T., Yamaguchi, S., Kano, M., Orii, T., Fujiki, Y., Osumi, T., & Hashimoto, T. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114946 · Cited by 73 · cited 2×
“The enzyme has been puriÐed from various sources, is a homotetramer of 42 kDa subunits and is localized in the mitochondrial matrix ; cDNA sequences corresponding to the rat (Fukao et al 1989) and human (Fukao et al 1990) enzyme have been determined.”
BackgroundGoodman, S. I., Kratz, L. E., DiGiulio, K. A., Biery, B. J., Goodman, K. E., Isaya, G., & Frerman, F. E. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.9.1493 · Cited by 71 · cited 1×
“Apart from SCAD, MCAD, LCAD, VLCAD and SBCAD, two additional acylCoA dehydrogenases have been identiÐed including isovaleryl-CoA dehydrogenase (IVD), Ðrst puriÐed and characterized by Ikeda and Tanaka (1983b) and glutarylCoA dehydrogenase (Goodman et al 1995).”
MethodGregersen, N., Andresen, B. S., Bross, P., Winter, V., diger, N. R., Engst, S., Christensen, E., Kelly, D. P., Strauss, A. W., K�lvraa, S., et al. (1991) · Human Genetics · doi:10.1007/bf00201539 · Cited by 70 · cited 1×
“Molecular basis of MCAD deÐciency : Studies in the early 1990s revealed the existence of a single, highly prevalent mutation among MCAD-deÐcient patients (Gregersen et al 1991 ; Kelly et al 1990 ; Yokota et al 1990).”
BackgroundDelta 3,delta 2-enoyl-CoA isomerases. Characterization of the mitochondrial isoenzyme in the rat.
Palosaari, P. M., Kilponen, J. M., Sormunen, R. T., Hassinen, I. E., & Hiltunen, J. K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39773-x · Cited by 69
Kamijo, T., Indo, Y., Souri, M., Aoyama, T., Hara, T., Yamamoto, S., Ushikubo, S., Rinaldo, P., Matsuda, I., Komiyama, A., et al. (1997) · Pediatric Research · doi:10.1203/00006450-199711000-00002 · Cited by 68 · cited 2×
“The name medium-chain 3-ketoacyl-CoA thiolase (MCKAT) is suggested (Kamijo et al 1997).”
BackgroundAoyama, T., Souri, M., Ueno, I., Kamijo, T., Yamaguchi, S., Rhead, W. J., Tanaka, K., & Hashimoto, T. (1995) · Europe PMC (PubMed Central) · Cited by 66
Rozen, R. R., Vockley, J., Zhou, L., Milos, R., Willard, J., Fu, K., Vicanek, C., Low-Nang, L., Torban, E., & Fournier, B. (1994) · Genomics · doi:10.1006/geno.1994.1617 · Cited by 66
Trifunctional enzyme deficiency: Adult presentation of a usually fatal β‐oxidation defect
Schaefer, J., Jackson, S., Turnbull, D. M., & Dick, D. J. (1996) · Annals of Neurology · doi:10.1002/ana.410400409 · Cited by 64
Very long chain acyl‐coenzyme A dehydrogenase deficiency with adult onset
Smelt, A. H. M., Poorthuis, B. J. H. M., Onkenhout, W., Scholte, H. R., Andresen, B. S., van Duinen, S. G., Gregersen, N. V., & Wintzen, A. R. (1998) · Annals of Neurology · doi:10.1002/ana.410430422 · Cited by 63 · cited 3×
“Onkenhout and colleagues (1995) have advocated the use of total fatty acids analysis of serum by GC-MS, which also shows profound abnormalities in cases of VLCAD deÐciency (Smelt et al 1998 ; Vianey-Saban et al 1998).”
BackgroundPalosaari, P. M., Vihinen, M., Mäntsälä, P., Alexson, S. E. H., Pihlajaniemi, T. A., & Hiltunen, J. K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99081-2 · Cited by 62
Hypoparathyroidism in mitochondrial trifunctional protein deficiency
Dionisi‐Vici, C., Garavaglia, B., Burlina, A., Bertini, E., Saponara, I., Sabetta, G., & Taroni, F. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70206-8 · Cited by 60 · cited 1×
“MT P-deÐciency : After its Ðrst description in 1992 by two di†erent groups (Jackson et al 1992 ; Wanders et al 1992), very few additional patients have been described (Brackett et al 1995 ; Dionisi-Vici et al 1996 ; Ibdah et al 1998 ; Ushikubo et al 1996).”
BackgroundIndo, Y., Yang‐Feng, T. L., Glassberg, R., & Tanaka, K. (1991) · Genomics · doi:10.1016/0888-7543(91)90068-p · Cited by 60
Souri, M., Aoyama, T., Orii, K. O., Yamaguchi, S., & Hashimoto, T. (1996) · PubMed · Cited by 59
Onkenhout, W., Venizelos, V., van der Poel, P. F. H., van den Heuvel, M. P., & Poorthuis, B. J. H. M. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1467 · Cited by 59
Olpin, S. E., Manning, N. J., Pollitt, R. J., & Clarke, S. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005358802096 · Cited by 58
Elfakhri, M., & Middleton, B. (1982) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(82)90244-2 · Cited by 56 · cited 1×
“The enzyme was found to be membrane-bound, reacting with medium- and long-chain substrates but not with the C4 short-chain substrate (El-Fakhri and Middleton 1982).”
BackgroundOrii, K. O. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1215 · Cited by 56
Watmough, N. J., Turnbull, D. M., Sherratt, H. S. A., & Bartlett, K. (1989) · Biochemical Journal · doi:10.1042/bj2620261 · Cited by 55
Osmundsen, H., & Bremer, J. (1977) · Biochemical Journal · doi:10.1042/bj1640621 · Cited by 55 · cited 2×
“Osmundsen and Bremer (1977) introduced a spectrophotometric assay for boxidation in intact mitochondria by following the reduction of ferricyanide at 425È 475 nm in a dual-wavelength spectrophotometer.”
MethodStructure and expression of the human mitochondrial acetoacetyl-CoA thiolase-encoding gene
Kano, M., Fukao, T., Yamaguchi, S., Orii, T., Osumi, T., & Hashimoto, T. (1991) · Gene · doi:10.1016/0378-1119(91)90623-j · Cited by 55
Vredendaal, P. J. C. M., van den Berg, I. E. T., Malingré, H. E. M., Stroobants, A. K., OldeWeghuis, D. E. M., & Berger, R. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0961 · Cited by 54
DiDonato, S., Gellera, C., Peluchetti, D., Uziel, G., Antonelli, A., Lus, G., & Rimoldi, M. (1989) · Annals of Neurology · doi:10.1002/ana.410250510 · Cited by 54
Tserng, K., & Jin, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99001-0 · Cited by 53 · cited 2×
“Tserng and Jin, however, found clear evidence for the involvement of NADPH and suggested the existence of a putative NADPHdependent reductase (Tserng and Jin 1991).”
BackgroundFukao, T., Kamijo, K., Osumi, T., Fujiki, Y., Yamaguchi, S., Orii, T., & Hashimoto, T. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122832 · Cited by 52
Luo, M. J., Mao, L. F., & Schulz, H. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1388 · Cited by 50 · cited 1×
“First, Schulz and coworkers (Luo et al 1995) identiÐed a new 3-hydroxyacyl-CoA dehydrogenase, called SCHMAD, reacting preferentially with 3-hydroxy-2-methylacyl-CoAs such as L-3-hydroxy-2-methylbutyryl-CoA, a metabolite of isoleucine.”
BackgroundAmino acid sequence of L‐3‐hydroxyacyl CoA dehydrogenase from pig heart muscle
Bitar, K. G., Pérez-Aranda, A., & Bradshaw, R. A. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80642-9 · Cited by 50 · cited 1×
“The amino acid sequence of mature pig heart SCHAD was determined (Bitar et al 1980), which allowed cloning of the human SCHAD cDNA (Vredendaal et al 1996) and resolution of the gene structure (Vredendaal et al 1999).”
MethodΔ3,5-Δ2,4-Dienoyl-CoA Isomerase from Rat Liver
Filppula, S. A., Yagi, A. I., Kilpeläinen, S. H., Novikov, D., FitzPatrick, D. R., Vihinen, M., Valle, D., & Hiltunen, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.349 · Cited by 50
Corydon, T. J., Bross, P., Jensen, T. G., Corydon, M. J., Lund, T. B., Jensen, U. B., Kim, J. J., Gregersen, N., & Bolund, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13065 · Cited by 49
A new case of short-chain acyl-CoA dehydrogenase deficiency with isolated ethylmalonic aciduria
Sewell, A., Herwig, J., Böhles, H. J., Rinaldo, P., Bhala, A., & Hale, D. E. (1993) · European Journal of Pediatrics · doi:10.1007/bf01957531 · Cited by 48 · cited 1×
“Patient 4 (Sewell et al 1993) Ðrst presented at 15 months with pneumonia, fever, tachypnoea and expiratory stridor.”
BackgroundLuo, M. J., Smeland, T. E., Shoukry, K., & Schulz, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41957-0 · Cited by 46 · cited 1×
“Direct enzyme activity measurements have shown the presence of *3,5,*2,4- dienoyl-CoA isomerase activity in mitochondria (Chen et al 1994 ; Luo et al 1994).”
BackgroundWanders, R. J. A., Denis, S. W., Ruiter, J. P. N., IJlst, L., & Dacremont, G. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00053-8 · Cited by 46
Self-citationHe, X., Shoukry, K., Chu, S. H., Yang, J. Y., Sprecher, H. W., & Schulz, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2428 · Cited by 46 · cited 1×
“*3,5,*2,4-Dienoyl-CoA isomerase activity has also been demonstrated in peroxisomes (He et al 1995).”
BackgroundThe long-chain acyl-CoA dehydrogenase deficiency.
Hale, D. E., Stanley, C. A., & Coates, P. M. (1990) · PubMed · Cited by 46
Olpin, S. E., Manning, N. J., CARPENTER, K., Middleton, B. S., & Pollitt, R. J. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800227 · Cited by 44 · cited 2×
“Incubation of(C14>0) intact Ðbroblasts with these fatty acids usually gives deÐcient rates of [3H]H2O production with most enzyme deÐciencies (Manning et al 1990 ; Olpin et al 1992 ; Ventura et al 1998).”
BackgroundMethodKanazawa, M., Ohtake, A., Abe, H., Yamamoto, S., Satoh, Y., Takayanagi, M., Niimi, H., Mori, M., & Hashimoto, T. (2017) · Enzyme and Protein · doi:10.1159/000468650 · Cited by 44
Dawson, D. B., Waber, L. J., Hale, D. E., & Bennett, M. J. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70505-8 · Cited by 43 · cited 1×
“Patient 6 (Dawson et al 1995) presented soon after birth with nystagmus, hypertonia and sluggishly reactive pupils.”
BackgroundWit-Peeters, E. M., Scholte, H. R., Akker, F. V. D., & de Nie, I. (1971) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(71)90252-9 · Cited by 43 · cited 1×
“Earlier studies (Wit-Peeters et al 1971) had provided suggestive evidence in favour of a separate enzyme since, upon puriÐcation of crotonase from calf-liver, the ratio of hydratase activities measured with crotonyl-CoA and hexadecenoyl-CoA increased from 5.3 to 420.”
ResultInfluentialAssay of l-3-hydroxyacyl-coenzyme A dehydrogenase with substrates of different chain lengths
He, X., Yang, S., & Schulz, H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90095-x · Cited by 42 · cited 1×
“SCHAD reacts preferentially with short- and medium-chain substrates (He et al 1989) (see Figure 3b).”
BackgroundCorti, O., DiDonato, S., & Finocchiaro, G. (1994) · Biochemical Journal · doi:10.1042/bj3030037 · Cited by 39 · cited 1×
“In the second mRNA, which codes for the peroxisomal human CAT, the mitochondrial targeting signal is disrupted by an intron so that initiation of translation takes place from a downstream AUG (Corti et al 1994).”
BackgroundKoivuranta, K., Hakkola, E. H., & Hiltunen, J. K. (1994) · Biochemical Journal · doi:10.1042/bj3040787 · Cited by 38
Dommes, V., Luster, W., CVETANOVIC, M., & Kunau, W. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06688.x · Cited by 36 · cited 1×
“The Ðrst mitochondrial 2,4-dienoyl-CoA reductase was puriÐed from bovine liver (Dommes et al 1982).”
MethodStereochemistry of Peroxisomal and Mitochondrial β‐oxidation of α‐methylacyl‐CoAs
Schmitz, W., & Conzelmann, E. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00434.x · Cited by 35 · cited 1×
“Studies, notably by Conzelmann and coworkers (Schmitz and Conzelmann 1997 ; Schmitz et al 1994, 1995), have led to the identiÐcation of a 2-methylacyl-CoA racemase, which can rapidly interconvert a variety of (R)- and (S)-2-methyl-branched-chain acyl-CoA esters.”
BackgroundYang, B.-Z., Heng, H. H., Ding, J.-H., & Roe, C. R. (1996) · Genomics · doi:10.1006/geno.1996.0533 · Cited by 35 · cited 1×
“The cDNA structures for both subunits have been determined both for rat (Kamijo et al 1993) and man (Kamijo et al 1994), and the structure of the human genes coding for the a- and b- subunits has been resolved (Yang et al 1996).”
BackgroundMild or absent clinical signs in twin sisters with short-chain acyl-CoA dehydrogenase deficiency
Ribes, A., Riudor, E., Garavaglia, B., Martínez, G., Arranz, A., Invernizzi, F., Briones, P., Lamantea, E., Sentís, M., Barceló, A., et al. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050819 · Cited by 34 · cited 2×
“Recently, twin sisters with SCAD deÐciency were reported with mild (case 8) to absent (case 9) clinical signs (Ribes et al 1998).”
BackgroundFitzPatrick, D. R., Germain‐Lee, E. L., & Valle, D. L. (1995) · Genomics · doi:10.1006/geno.1995.1077 · Cited by 33
Mitochondrial β-Oxidation of 2-Methyl Fatty Acids in Rat Liver
Mao, L. F., Chu, C., Luo, M. J., Simon, A., Abbas, A. S., & Schulz, H. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1389 · Cited by 32 · cited 1×
“Recent data from Schulz and coworkers (Mao et al 1995) and ourselves (Wanders et al 1998) have shed some light on this issue.”
BackgroundWillard, J., Vicanek, C., Battaile, K. P., Veldhoven, P. P. V., Fauq, A. H., Rozen, R. R., & Vockley, J. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0290 · Cited by 32 · cited 7×
“Accordingly, SCHMAD is probably not involved in the b-oxidation of fatty acids but only in the oxidation of isoleucine, catalysing the third step in the b-oxidation of 2-methylbutyryl-CoA following (1) SBCAD (2- methylbutyryl-CoA ] tiglyl-CoA) and (2) crotonase (tiglyl-CoA ] 3-hydroxy-2methylbutyryl-CoA).”
BackgroundInfluentialcDNA cloning of rat liver 2,4-dienoyl-CoA reductase
Hirose, A., Kamijo, K., Osumi, T., Hashimoto, T., & Mizugaki, M. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90109-f · Cited by 32
Müller‐Newen, G., & Stoffel, W. (1991) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1991.372.2.613 · Cited by 32
Baerlocher, K. E., Steinmann, B. U., Aguzzi, A., Krähenbühl, S., Roe, C. R., & Vianey‐Saban, C. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005319120751 · Cited by 31 · cited 1×
“Patient 7 (Baerlocher et al 1997) also presented with feeding problems and failure to thrive.”
BackgroundSchmidt‐Sommerfeld, E., Penn, D., Durán, M., Bennett, M. J., Santer, R., & Stanley, C. A. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80009-0 · Cited by 31
Purification and Mechanism of .DELTA.3,.DELTA.5-t-2,t-4-Dienoyl-CoA Isomerase from Rat Liver
Chen, L.-S., Jin, S.-J., & Tserng, K. (1994) · Biochemistry · doi:10.1021/bi00200a039 · Cited by 31 · cited 1×
“Direct enzyme activity measurements have shown the presence of *3,5,*2,4- dienoyl-CoA isomerase activity in mitochondria (Chen et al 1994 ; Luo et al 1994).”
BackgroundMolecular cloning of cDNA species for rat and mouse liver α-methylacyl-CoA racemases
SCHMITZ, W., HELANDER, H. M., HILTUNEN, J. K., & CONZELMANN, E. (1997) · Biochemical Journal · doi:10.1042/bj3260883 · Cited by 30
Luo, M. J., He, X. Y., Sprecher, H. W., & Schulz, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1348 · Cited by 29 · cited 3×
“As with the long-chain enoyl-CoA hydratase described above, LCHAD is now known to be one of the three constituents of the trifunctional protein (MTP) (Carpenter et al 1992 ; Luo et al 1993 ; Uchida et al 1992).”
BackgroundOccurrence of a long-chain Δ3,Δ2-enoyl-CoA isomerase in rat liver
Kilponen, J. M., Palosaari, P. M., & Hiltunen, J. K. (1990) · Biochemical Journal · doi:10.1042/bj2690223 · Cited by 29
Durán, M., Cleutjens, C. B. J. M., Ketting, D., DORLAND, L., de Klerk, J. B. C., van Sprang, F. J., & Berger, R. (1992) · Pediatric Research · doi:10.1203/00006450-199201000-00007 · Cited by 28
Stoffel, W., & Grol, M. (1978) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1978.359.2.1777 · Cited by 28
Vredendaal, P. J. C. M., van den Berg, I. E. T., Stroobants, A. K., van der A, D. L., Malingré, H. E. M., & Berger, R. (1998) · Mammalian Genome · doi:10.1007/s003359900860 · Cited by 27
The existence of two mitochondrial isoforms of 2,4‐dienoyl‐CoA reductase in the rat
Hakkola, E. H., & Hiltunen, J. K. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18023.x · Cited by 27 · cited 1×
“An isoform of mitochondrial 2,4-dienoyl-CoA reductase has been identiÐed (Hakkola and Hiltunen 1993).”
BackgroundAmendt, B. A., Fréneaux, E., Reece, C., Wood, P. A., & Rhead, W. J. (1992) · Pediatric Research · doi:10.1203/00006450-199206000-00003 · Cited by 26
Abe, H., Ohtake, A., Yamamoto, S., Sato, Y., Takayanagi, M., Amaya, Y., Takiguchi, M., Sakuraba, H., Suzuki, Y., Mori, M., et al. (1993) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(93)90160-f · Cited by 26 · cited 1×
“The cDNA sequences corresponding to the rat (Arakawa et al 1987 ; Miura et al 1986) and human (Abe et al 1993) mitochondrial “general Ï thiolase have been determined.”
MethodLargillière, C., Vianey‐Saban, C., Fontaine, M., Bertrand, C., Kacet, N., & Farriaux, J. P. (1995) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.73.2.f103 · Cited by 25 · cited 1×
“…in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of 30 patients in 27…”
BackgroundPurification and Characterization of an alpha-Methylacyl-CoA Racemase from Human Liver
Schmitz, W., Albers, C., Fingerhut, R., & Conzelmann, E. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0815d.x · Cited by 25 · cited 1×
“Studies, notably by Conzelmann and coworkers (Schmitz and Conzelmann 1997 ; Schmitz et al 1994, 1995), have led to the identiÐcation of a 2-methylacyl-CoA racemase, which can rapidly interconvert a variety of (R)- and (S)-2-methyl-branched-chain acyl-CoA esters.”
BackgroundIndo, Y., Coates, P. M., Hale, D. E., & Tanaka, K. (1991) · Pediatric Research · doi:10.1203/00006450-199109000-00001 · Cited by 24 · cited 12×
“…et al 1989 ; MCAD, Matsubara et al 1986 ; LCAD, Matsubara et al 1989) and human (SCAD, Naito et al 1989 ; MCAD, Matsubara et al 1986 ; Kelly et al 1987 ; LCAD, Indo et al 1991b) acyl-CoA dehdyrogenases have all been determined, which allowed calculation of their true molecular mass (42È45 kDa).”
BackgroundInfluentialCoates, P. M., Indo, Y., Young, D., Hale, D. E., & Tanaka, K. (1992) · Pediatric Research · doi:10.1203/00006450-199201000-00006 · Cited by 23
Sluysmans, T., Tuerlinckx, D., Hubinont, C., Verellen‐Dumoulin, C., Brivet, M., & Vianey‐Saban, C. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)80073-x · Cited by 20 · cited 1×
“…patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of 30 patients in 27 families (Vianey-Saban et al 1998).”
BackgroundAmendt, B. A., & Rhead, W. J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112096 · Cited by 19 · cited 1×
“22 (1999) T ritium release from speciÐcally labelled [2,3-3H]acyl-CoA esters : Rhead and coworkers introduced the use of [2,3-3H]acyl-CoA esters for measurement of SCAD (Amendt et al 1987) and MCAD (Amendt and Rhead 1985).”
MethodMitochondropathy presenting with non‐ketotic hypoglycaemia as 3‐hydroxydicarboxylic aciduria
Mayatepek, E., Wanders, R. J. A., Becker, M., Bremer, H. J., & Hoffmann, G. F. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711780 · Cited by 18
Self-citationSchmidt‐Sommerfeld, E., Bobrowski, P. J., Penn, D., Rhead, W. J., Wanders, R. J. A., & Bennett, M. J. (1998) · Pediatric Research · doi:10.1203/00006450-199808000-00012 · Cited by 18
Self-citationMitochondrial very long‐chain acyl‐CoA dehydrogenase deficiency with a mild clinical course
Merinero, B., Pérez‐Cerdá, C., García, M. J., Gangoiti, J. A., Font, L. M., Silva, M. T. G., Vianey‐Saban, C., Durán, M., & Ugarte, M. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799422 · Cited by 16 · cited 2×
“…a variety of dicarboxylic acids including adipic, suberic, sebacic and dodecanedioic acids, although several reports have documented mild (Hale et al 1985 ; Merinero et al 1996) to fully normal dicarboxylics both during and between attacks (Hale et al 1990 ; Ogilvie et al 1994 ; Smelt et al 1998).”
BackgroundIJlst, L., & Wanders, R. J. A. (1993) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329303000311 · Cited by 16 · cited 3×
“The ferricenium assay (Lehman et al 1990) is suitable for establishing whether VLCAD is deÐcient (IJlst and Wanders 1993a) but produces unrealistically high residual activities, as concluded from a recent comparative study we performed in which the ETF reduction, HPLC and ferricenium methods were…”
BackgroundMethodSelf-citationKetonuria and medium‐chain acyl‐CoA dehydrogenase deficiency
Patel, J. S., & Leonard, J. V. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711392 · Cited by 13 · cited 1×
“This also applies to the ketone bodies : usually there is hypoketonuria but exceptions have been reported (Patel and Leonard 1995).”
BackgroundSingh, H., Beckman, K., & Poulos, A. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37465-4 · Cited by 13
Purification and Characterization of Bovine Liver.3-cis-2-trans-Enoyl-CoAIsomerase
Euler-Bertram, S., & Stoffel, W. (1990) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1990.371.2.603 · Cited by 12
cDNA cloning of mitochondrial Δ3, Δ2-enoyl-CoA isomerase of rat liver
Tomioka, Y., Hirose, A., Moritani, H., Hishinuma, T., Hashimoto, T., & Mizugaki, M. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90473-d · Cited by 11 · cited 1×
“Short-chain *3,*2-enoyl-CoA isomerase has been crystallized (Zeelen et al 1990) and its cDNA has been cloned and sequenced (Muller-Newen and Sto†el 1991 ; Palosaari et al 1991 ; Tomioka et al 1992).”
BackgroundNiezen‐Koning, K. E., Wanders, R. J. A., Nagel, G. T., Sewell, A., & Heymans, H. S. A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90232-1 · Cited by 10 · cited 1×
“22 (1999) (Niezen-Koning et al 1994).”
Self-citationCrystallographic studies of 3-ketoacylCoA thiolase from yeast Saccharomyces cerevisiae
Zeelen, J., Wierenga, R. K., Erdmann, R., & Kunau, W. H. (1990) · Journal of Molecular Biology · doi:10.1016/s0022-2836(05)80338-9 · Cited by 10
Molecular cloning of cDNA for rat mitochondrial 3-oxoacyl-CoA thiolase
Miura, S., Takiguchi, M., Matsue, H., Amaya, Y., Tatibana, M., Shigesada, K., Osumi, T., Hashimoto, T., & Mori, M. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09422.x · Cited by 7
IJlst, L., & Wanders, R. J. A. (1993) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711683 · Cited by 6 · cited 3×
“The ferricenium assay (Lehman et al 1990) is suitable for establishing whether VLCAD is deÐcient (IJlst and Wanders 1993a) but produces unrealistically high residual activities, as concluded from a recent comparative study we performed in which the ETF reduction, HPLC and ferricenium methods were…”
BackgroundMethodSelf-citationMeasurement of acyl‐CoA dehydrogenase activity in cultured skin fibroblasts and blood platelets
Taylor, R. W., Jackson, S., Pourfarzam, M., Bartlett, K., & Turnbull, D. M. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800014 · Cited by 6 · cited 1×
“We and others have been using this method for some years and it is now clear that the method is deÐnitely unsuitable for MCAD analysis (Taylor et al 1992).”
MethodNiezen‐Koning, K. E., Wanders, R. J. A., Nagel, G. T., IJlst, L., & Heymans, H. S. A. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90023-g · Cited by 5 · cited 1×
“The same principle has also been used to set up assays for LCAD (Niezen-Koning et al 1992) and SCAD J. Inher.”
MethodSelf-citationHypoketonuric 3‐hydroxydicarboxylic aciduria in five patients with glycogen storage disease
Mize, C. E., Waber, L. J., Anderson, T., & Bennett, M. J. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005354701187 · Cited by 4
Fatty acid oxidation in soluble systems of mammalian origin: the beginnings.
Beinert, H. (1990) · PubMed · Cited by 4
Research works printed but not linked: 1
- VredendaalPJ van denBergIET StroobantsAK Van DerADL MalingreHE BergerR(1999)Structural organisation of the human short‐chainL‐3‐hydroxyacyl‐CoA dehydrogenase gene.Mamm Genome(in press)..
Cited by
A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
Houten, S. M., & Wanders, R. J. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9061-2 · Cited by 1,020
“For almost each enzyme involved in FAO, inherited defects have been described (Wanders et al. 1999; Rinaldo et al. 2002).”
BackgroundSelf-citationFatty Acid Oxidation Disorders
Rinaldo, P., Matern, D., & Bennett, M. J. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.154705 · Cited by 479
The Properties of Lauric Acid and Their Significance in Coconut Oil
Dayrit, F. M. (2015) · Journal of the American Oil Chemists' Society · doi:10.1007/s11746-014-2562-7 · Cited by 479
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Control of mitochondrial β-oxidation flux
Eaton, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00024-8 · Cited by 411
Metadata
- Authors
- Wanders, R. J. A., Vreken, P., den Boer, M. E. J., Wijburg, F. A., Van Gennip, A. H., & IJlst, L.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Departments of Clinical Chemistry Academic Medical Center, University of Amsterdam The Netherlands
- Corresponding author
- Wanders, R. J. A.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 22
- Issue
- 4
- Pages
- 442-487
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2147457396
- Cited by
- 257
- References
- 180
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 12 · 2023: 4 · 2022: 9 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 12 · 2013: 13 · 2012: 5
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- fatty acid beta-oxidation disorders, inborn errors of metabolism, VLCAD, mitochondrial trifunctional protein, acylcarnitines, tandem mass spectrometry, branched-chain fatty acids, polyunsaturated fatty acids, enzyme defects, molecular diagnosis, treatment options
- MeSH terms
- Acyl Coenzyme A, Fatty Acids, Fatty Acids, Unsaturated, Humans, Lipid Metabolism, Inborn Errors, Mitochondria, Oxidation-Reduction, Prenatal Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.